Senna S (P and L Development of New York Corporation)
Welcome to the PulseAid listing for the Senna S drug offered from P and L Development of New York Corporation. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
| LABELER NAME / MANUFACTURER: | P and L Development of New York Corporation |
| NON-PROPRIETARY NAME: | docusate sodium and sennosides |
| SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
| TYPE: | HUMAN OTC DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET |
| MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
| START MARKETING DATE: | 2012-05-15 |
| END MARKETING DATE: | 0000-00-00 |
Senna S HUMAN OTC DRUG Details:
| Item Description | Senna S from P and L Development of New York Corporation |
| LABELER NAME: | P and L Development of New York Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
| START MARKETING DATE: | 2012-05-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 59726-160_d6abd9ef-7589-4e86-a531-a7d7dce815df |
| PRODUCT NDC: | 59726-160 |
| APPLICATION NUMBER: | part334 |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers:
